Drug-induced phospholipidosis of the kidney suspected to be caused by atomoxetine.

Drug-induced phospholipidosis (DIP) is characterized by intracellular accumulation of phospholipids with lamellar body formation secondary to drug-altered lipid metabolism, which can trigger inflammation and histopathological changes. Fabry disease a…

Preview only. Read the full abstract at the source